Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Index
-
Market Cap
0.76M
Enterprise Value
4.92M
Income
-15.33M
Sales
24.24M
Book/sh
-1.28
Cash/sh
1.03
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
44
IPO
May 20, 2020
P/E
-
Forward P/E
-
PEG
-
P/S
0.03
P/B
-
P/C
0.45
P/FCF
-
EV/EBITDA
-
EV/Sales
0.20
Quick Ratio
0.55
Current Ratio
0.66
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / Yes
EPS (ttm)
-53.71
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
74.93% 43.53%
Sales past 3/5Y
-2.09% 27.02%
EPS Y/Y TTM
-127.87%
Sales Y/Y TTM
-35.33%
EPS Q/Q
55.66%
Sales Q/Q
-88.28%
Insider Own
34.40%
Insider Trans
0.00%
Inst Own
2.76%
Inst Trans
12.59%
ROA
-65.62%
ROE
-3649.41%
ROIC
-
Gross Margin
8.89%
Oper. Margin
-31.87%
Profit Margin
-63.27%
SMA20
-36.95%
SMA50
-70.30%
SMA200
-94.75%
Trades
Shs Outstand
1.65M
Shs Float
1.08M
52W High
62.40 -99.26%
52W Low
0.45 2.24%
Volatility
19.54% 14.71%
ATR (14)
0.17
RSI (14)
26.28
Beta
2.61
Rel Volume
0.00
Avg Volume
2.69M
Volume
315
Perf Week
-24.82%
Perf Month
-69.33%
Perf Quarter
-85.53%
Perf Half Y
-93.13%
Perf YTD
-98.90%
Perf Year
-98.46%
Perf 3Y
-99.39%
Perf 5Y
-99.99%
Perf 10Y
-
Prev Close
0.50
Price
0.46
Change %
-7.05%
Consensus
Buy
Avg. Price Target
$180.00
Implied Upside
+39,021.9%
Analysts2incl. previous ratings
Rating Distribution2 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 05, 2021Initiated
RROTH Capital
Buy$8+1,638.8%
Jul 14, 2021Initiated
DDesjardins
Buy
IM Cannabis Corp. engages in the production and sale of medical cannabis products. It offers dry flower products and cannabis oil products under the IMC brand. The company was founded on March 7, 1980 and is headquartered in Glil Yam, Israel.
CEO & Executive DirectorMr. Oren Shuster
Chief Financial OfficerMr. Asi Levi
Chief Executive Officer of AdjupharmMr. Richard Balla
Director Investor & Public RelationsAnna Taranko
Chief Executive Officer of the IMC HoldingsMr. Eyal Fisher